Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia

NCT04403763 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

80

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic considerations

Conditions

Presbyopia

Interventions

DRUG: AGN-241622
DRUG: Vehicle

Sponsor

AbbVie